Johnson & Johnson
News and overview for Johnson & Johnson
In Pictures: The 10 Most-Liked Sports Figures - Forbes.com
Forbes | 38 days 22 hours 18 minutes ago
The latest surveys conducted by E-Poll Market Research of Encino, Calif., show that sports fans generally take to athletes they see as trustworthy and sincere. Those are the most common traits associated with our list of America's 10 most-liked sports figures.
In Pictures: 10 Tips On Raising A Young Mogul - Forbes.com
Forbes | 45 days 9 hours 15 minutes ago
Every parent wants to believe his or her child is gifted. For sprouts with truly serious potential, the pangs to make a few bucks can come on early and strong. That can be both a blessing and a curse. Push too hard and the entrepreneurial flame might burn out; patronize (or ignore) and it might engulf her. With that danger in mind, here are 10 tips for rearing a budding tycoon.
Johnson & Johnson cutting up to 7% of jobs - MarketWatch
MarketWatch | 20 days 19 hours 36 minutes ago
JNJ
Johnson & Johnson, Goldman Sachs, CIT in focus - MarketWatch
MarketWatch | 41 days 19 hours 34 minutes ago
European shares traded with mild losses as investors held back from building on multi-month highs. Shares in Shanghai and Hong Kong led a broad advance in Asia, as automobile stocks rose on strong sales data and power utilities rallied on an improving economic outlook.
Johnson & Johnson to cut up to 8,200 jobs - MarketWatch
MarketWatch | 20 days 17 hours 44 minutes ago
J&J /quotes/comstock/13*!jnj/quotes/nls/jnj (JNJ 59.35, -0.14, -0.24%) said that it expects its cost-cutting plan to be fully implemented by 2011.
Addex ADX48621 Positive Primate Parkinson's Data [Press Release]
MarketWire | 1 minute ago
GENEVA -- (Marketwire) -- 11/24/09 -- Addex Pharmaceuticals (SWISS: ADXN), the allosteric modulation company, announced today that in a non-human primate model of Parkinson's disease (PD) levodopa induced dyskinesia (LID), ADX48621 statistically and significantly inhibited LID. More specifically, the compound inhibited dose dependently both chorea and dystonia, the two major components of LID, without affecting the beneficial effects of levodopa. There is currently no approved treatment avai...
ALLIANCE TRUST PLC - Interim Management Statement [Press Release]
PRNewswire | 1 minute ago
INTERIM MANAGEMENT STATEMENT
Mead Johnson to File Registration Statement; Comments on Bristol-Myers Squibb Announcement to Split-off Mead Johnson [Press Release]
Business Wire | 8 days 8 hours 32 minutes ago
Mead Johnson Nutrition Company (NYSE: MJN) announced today that it intends to file a Registration Statement on Form S-4 with the Securities and Exchange Commission (SEC), which includes details of a proposed exchange offer whereby Bristol-Myers Squibb Company (BMS) shareholders can exchange some, none or all of their shares of BMS common stock for shares of Mead Johnson common stock. If conditions to completion of the exchange offer are met, BMS will dispose of its entire ownership interest i...
Johnson & Johnson Announces Restructuring Initiatives for Sustainable Growth [Press Release]
PRNewswire | 20 days 14 hours 2 minutes ago
Johnson & Johnson Announces Restructuring Initiatives for Sustainable Growth Continues to...3 NEW BRUNSWICK, N.J., Nov. 3 /PRNewswire-FirstCall/ -- Johnson & Johnson today announced global restructuring initiatives designed to...
Organizer awards first Ed Johnson college scholarship
Chattanooga Times Free Press (Tenn.) | 1 day 2 hours 47 minutes ago
LaFrederick Thirkill wanted to make sure that lynching victim Ed Johnson’s story remained a part of Chattanooga history.
Earvin Magic Johnson to Speak At Magic@50 Community Health Expo in Los Angeles [Press Release]
Business Wire | 7 days 14 hours 14 minutes ago
Aetna (NYSE: AET) and Magic Johnson Enterprises (MJE) announced today that Earvin “Magic” Johnson will be the featured speaker at a free “Magic@50” Community Health EXPO at the Nate Holden Performing Arts Center (4718 West Washington Blvd., Los Angeles, CA 90016) on Saturday, November 21.
Entrepreneur is Encouraging the World to Pay It Forward [Press Release]
Business Wire | 11 hours 53 minutes ago
A 28-year-old entrepreneur from Salt Lake City, Utah wants to change the world. Charley Johnson, the executive vice president and co-owner of SnugZ USA (a promotional products company that is also the largest U.S. manufacturer of lanyards—visit www.snugzusa.com) is partnering with the Pay it Forward Foundation in embarking on an international campaign to have individuals “Pay It Forward.”
Johnson & Johnson Reports 2009 Third-Quarter Results: [Press Release]
PRNewswire | 41 days 15 hours 47 minutes ago
Johnson & Johnson Reports 2009 Third-Quarter Results: Sales of $15.1 Billion Decreased...13 NEW BRUNSWICK, N.J., Oct. 13 /PRNewswire-FirstCall/ -- Johnson & Johnson today announced sales of $15.1 billion for the third quarter...
AmSurg Names John W. Popp, Jr., M.D. To Board of Directors [Press Release]
Business Wire | 10 hours 32 minutes ago
AmSurg Corp. (NASDAQ: AMSG), today announced the appointment of John W. Popp, Jr., M.D. to its Board of Directors. Dr. Popp is Clinical Professor of Medicine at the University of South Carolina School of Medicine and a Medical Director for Centocor, Inc., a unit of Johnson and Johnson, which provides innovative biomedicines for debilitating immune disorders. Dr. Popp is a board-certified internist and gastroenterologist. Since 1998, he has served on the Board of Trustees for the American Coll...
Vaccines become more attractive to drug developers
BIO SmartBrief | 1 day 2 hours 32 minutes ago
...packaging plant in Pennsylvania in a bid to topple Merck & Co. as a global leader in vaccine manufacturing, while Johnson & Johnson plans to build a full vaccine portfolio that includes a universal flu shot and a vaccine for Alzheimer's disease...
0 Results
Sign up for FDLI SmartBrief
Company Overview
| Company: | Johnson & Johnson |
|---|---|
| Industry: | Pharmaceuticals Manufacturers |
| Website: | http://www.jnj.com |
It's nearly impossible to get well without Johnson & Johnson (J&J). The diversified health care giant operates in three segments through more than 250 operating companies located in some 60 countries. Its Pharmaceuticals division makes drugs for an array of ailments, such as neurological conditions, blood disorders, autoimmune diseases, and pain. Top sellers are schizophrenia medication Risperdal and psoriasis drug Remicade. J&J's Medical Devices and Diagnostics division offers surgical equipment, monitoring devices, orthopedic products, and contact lenses, among other things. Its Consumer segment makes over-the-counter drugs and products for baby care, skin care, oral care, first aid, and women's health.
Key Numbers
| Sales in U.S. Dollars (mil.) | 63,747 (2008) |
|---|---|
| One-year % Growth in Sales | 4.3 (2008) |
| Net Income in U.S. Dollars (mil.) | 12,949 (2008) |
| One-year % Growth in Net Income | 22.4 (2008) |
| Number of Employees | 118,700 (2008) |
| One-year % Growth in Number of Employees | -0.4 (2008) |
| Fiscal Year-End | December |